nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethadione—CYP2C8—Mometasone—systemic scleroderma	0.265	0.416	CbGbCtD
Trimethadione—CYP2C9—Leflunomide—systemic scleroderma	0.119	0.187	CbGbCtD
Trimethadione—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.106	0.166	CbGbCtD
Trimethadione—CYP2C19—Prednisone—systemic scleroderma	0.0709	0.111	CbGbCtD
Trimethadione—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0428	0.0671	CbGbCtD
Trimethadione—CYP3A4—Prednisone—systemic scleroderma	0.0343	0.0537	CbGbCtD
Trimethadione—CYP2C9—cardial valve—systemic scleroderma	0.00461	0.701	CbGeAlD
Trimethadione—Neutropenia—Mycophenolic acid—systemic scleroderma	0.00137	0.00386	CcSEcCtD
Trimethadione—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00137	0.00386	CcSEcCtD
Trimethadione—Agranulocytosis—Azathioprine—systemic scleroderma	0.00135	0.00381	CcSEcCtD
Trimethadione—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00377	CcSEcCtD
Trimethadione—Anorexia—Pentoxifylline—systemic scleroderma	0.00133	0.00376	CcSEcCtD
Trimethadione—Weight decreased—Mycophenolic acid—systemic scleroderma	0.00133	0.00374	CcSEcCtD
Trimethadione—Alopecia—Captopril—systemic scleroderma	0.00132	0.00372	CcSEcCtD
Trimethadione—Haemoglobin—Azathioprine—systemic scleroderma	0.00131	0.00369	CcSEcCtD
Trimethadione—Eosinophilia—Lisinopril—systemic scleroderma	0.00131	0.00368	CcSEcCtD
Trimethadione—Haemorrhage—Azathioprine—systemic scleroderma	0.0013	0.00367	CcSEcCtD
Trimethadione—Epistaxis—Leflunomide—systemic scleroderma	0.00129	0.00364	CcSEcCtD
Trimethadione—Agranulocytosis—Leflunomide—systemic scleroderma	0.00128	0.0036	CcSEcCtD
Trimethadione—Insomnia—Pentoxifylline—systemic scleroderma	0.00127	0.00357	CcSEcCtD
Trimethadione—Pancytopenia—Lisinopril—systemic scleroderma	0.00125	0.00353	CcSEcCtD
Trimethadione—Hiccups—Prednisone—systemic scleroderma	0.00125	0.00352	CcSEcCtD
Trimethadione—Somnolence—Pentoxifylline—systemic scleroderma	0.00124	0.0035	CcSEcCtD
Trimethadione—Haemoglobin—Leflunomide—systemic scleroderma	0.00124	0.00348	CcSEcCtD
Trimethadione—Neutropenia—Lisinopril—systemic scleroderma	0.00124	0.00348	CcSEcCtD
Trimethadione—Epistaxis—Mycophenolic acid—systemic scleroderma	0.00123	0.00347	CcSEcCtD
Trimethadione—Erythema multiforme—Azathioprine—systemic scleroderma	0.00123	0.00347	CcSEcCtD
Trimethadione—Hepatitis—Leflunomide—systemic scleroderma	0.00123	0.00347	CcSEcCtD
Trimethadione—Haemorrhage—Leflunomide—systemic scleroderma	0.00123	0.00347	CcSEcCtD
Trimethadione—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00122	0.00344	CcSEcCtD
Trimethadione—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00122	0.00343	CcSEcCtD
Trimethadione—Ill-defined disorder—Captopril—systemic scleroderma	0.00121	0.0034	CcSEcCtD
Trimethadione—Weight decreased—Lisinopril—systemic scleroderma	0.0012	0.00337	CcSEcCtD
Trimethadione—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.00118	0.00332	CcSEcCtD
Trimethadione—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00117	0.00331	CcSEcCtD
Trimethadione—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.00117	0.00331	CcSEcCtD
Trimethadione—Malaise—Captopril—systemic scleroderma	0.00117	0.0033	CcSEcCtD
Trimethadione—Erythema multiforme—Leflunomide—systemic scleroderma	0.00116	0.00328	CcSEcCtD
Trimethadione—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00115	0.00325	CcSEcCtD
Trimethadione—Alopecia—Azathioprine—systemic scleroderma	0.00115	0.00324	CcSEcCtD
Trimethadione—Anorexia—Mometasone—systemic scleroderma	0.00115	0.00324	CcSEcCtD
Trimethadione—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00114	0.00322	CcSEcCtD
Trimethadione—Epistaxis—Lisinopril—systemic scleroderma	0.00111	0.00313	CcSEcCtD
Trimethadione—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00111	0.00312	CcSEcCtD
Trimethadione—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0031	CcSEcCtD
Trimethadione—Agranulocytosis—Lisinopril—systemic scleroderma	0.0011	0.0031	CcSEcCtD
Trimethadione—Discomfort—Captopril—systemic scleroderma	0.00109	0.00308	CcSEcCtD
Trimethadione—Alopecia—Leflunomide—systemic scleroderma	0.00109	0.00306	CcSEcCtD
Trimethadione—Paraesthesia—Mometasone—systemic scleroderma	0.00108	0.00305	CcSEcCtD
Trimethadione—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00305	CcSEcCtD
Trimethadione—Hepatitis—Lisinopril—systemic scleroderma	0.00106	0.00298	CcSEcCtD
Trimethadione—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00105	0.00296	CcSEcCtD
Trimethadione—Decreased appetite—Mometasone—systemic scleroderma	0.00105	0.00296	CcSEcCtD
Trimethadione—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00295	CcSEcCtD
Trimethadione—Fatigue—Mometasone—systemic scleroderma	0.00104	0.00293	CcSEcCtD
Trimethadione—Thrombocytopenia—Captopril—systemic scleroderma	0.00104	0.00293	CcSEcCtD
Trimethadione—Alopecia—Mycophenolic acid—systemic scleroderma	0.00104	0.00292	CcSEcCtD
Trimethadione—Malaise—Azathioprine—systemic scleroderma	0.00102	0.00288	CcSEcCtD
Trimethadione—Leukopenia—Azathioprine—systemic scleroderma	0.00102	0.00286	CcSEcCtD
Trimethadione—Anorexia—Captopril—systemic scleroderma	0.00101	0.00285	CcSEcCtD
Trimethadione—Asthenia—Pentoxifylline—systemic scleroderma	0.001	0.00283	CcSEcCtD
Trimethadione—Erythema multiforme—Lisinopril—systemic scleroderma	0.001	0.00282	CcSEcCtD
Trimethadione—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000994	0.0028	CcSEcCtD
Trimethadione—Pruritus—Pentoxifylline—systemic scleroderma	0.00099	0.00279	CcSEcCtD
Trimethadione—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000988	0.00278	CcSEcCtD
Trimethadione—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000981	0.00276	CcSEcCtD
Trimethadione—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.000973	0.00274	CcSEcCtD
Trimethadione—Malaise—Leflunomide—systemic scleroderma	0.000966	0.00272	CcSEcCtD
Trimethadione—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000963	0.00271	CcSEcCtD
Trimethadione—Vertigo—Leflunomide—systemic scleroderma	0.000962	0.00271	CcSEcCtD
Trimethadione—Insomnia—Captopril—systemic scleroderma	0.000959	0.0027	CcSEcCtD
Trimethadione—Leukopenia—Leflunomide—systemic scleroderma	0.000959	0.0027	CcSEcCtD
Trimethadione—Abdominal pain—Mometasone—systemic scleroderma	0.000955	0.00269	CcSEcCtD
Trimethadione—Discomfort—Azathioprine—systemic scleroderma	0.000954	0.00269	CcSEcCtD
Trimethadione—Paraesthesia—Captopril—systemic scleroderma	0.000953	0.00268	CcSEcCtD
Trimethadione—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000948	0.00267	CcSEcCtD
Trimethadione—Somnolence—Captopril—systemic scleroderma	0.000943	0.00266	CcSEcCtD
Trimethadione—Alopecia—Lisinopril—systemic scleroderma	0.000934	0.00263	CcSEcCtD
Trimethadione—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000931	0.00262	CcSEcCtD
Trimethadione—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000926	0.00261	CcSEcCtD
Trimethadione—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000926	0.00261	CcSEcCtD
Trimethadione—Decreased appetite—Captopril—systemic scleroderma	0.000922	0.0026	CcSEcCtD
Trimethadione—Malaise—Mycophenolic acid—systemic scleroderma	0.000922	0.0026	CcSEcCtD
Trimethadione—Vertigo—Mycophenolic acid—systemic scleroderma	0.000918	0.00259	CcSEcCtD
Trimethadione—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000915	0.00258	CcSEcCtD
Trimethadione—Fatigue—Captopril—systemic scleroderma	0.000915	0.00258	CcSEcCtD
Trimethadione—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000906	0.00255	CcSEcCtD
Trimethadione—Discomfort—Leflunomide—systemic scleroderma	0.000901	0.00254	CcSEcCtD
Trimethadione—Vomiting—Pentoxifylline—systemic scleroderma	0.00089	0.00251	CcSEcCtD
Trimethadione—Lymphadenopathy—Methotrexate—systemic scleroderma	0.000889	0.0025	CcSEcCtD
Trimethadione—Rash—Pentoxifylline—systemic scleroderma	0.000883	0.00249	CcSEcCtD
Trimethadione—Dermatitis—Pentoxifylline—systemic scleroderma	0.000882	0.00248	CcSEcCtD
Trimethadione—Headache—Pentoxifylline—systemic scleroderma	0.000877	0.00247	CcSEcCtD
Trimethadione—Feeling abnormal—Captopril—systemic scleroderma	0.000874	0.00246	CcSEcCtD
Trimethadione—Gastrointestinal pain—Captopril—systemic scleroderma	0.000867	0.00244	CcSEcCtD
Trimethadione—Asthenia—Mometasone—systemic scleroderma	0.000867	0.00244	CcSEcCtD
Trimethadione—Irritability—Prednisone—systemic scleroderma	0.000866	0.00244	CcSEcCtD
Trimethadione—Discomfort—Mycophenolic acid—systemic scleroderma	0.00086	0.00242	CcSEcCtD
Trimethadione—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000856	0.00241	CcSEcCtD
Trimethadione—Pruritus—Mometasone—systemic scleroderma	0.000855	0.00241	CcSEcCtD
Trimethadione—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000854	0.00241	CcSEcCtD
Trimethadione—Abdominal pain—Captopril—systemic scleroderma	0.000839	0.00236	CcSEcCtD
Trimethadione—Anorexia—Leflunomide—systemic scleroderma	0.000833	0.00235	CcSEcCtD
Trimethadione—Nausea—Pentoxifylline—systemic scleroderma	0.000831	0.00234	CcSEcCtD
Trimethadione—Malaise—Lisinopril—systemic scleroderma	0.00083	0.00234	CcSEcCtD
Trimethadione—Vertigo—Lisinopril—systemic scleroderma	0.000827	0.00233	CcSEcCtD
Trimethadione—CACNA1G—digestive system—systemic scleroderma	0.000826	0.126	CbGeAlD
Trimethadione—Leukopenia—Lisinopril—systemic scleroderma	0.000824	0.00232	CcSEcCtD
Trimethadione—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000819	0.00231	CcSEcCtD
Trimethadione—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000817	0.0023	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000804	0.00226	CcSEcCtD
Trimethadione—Anorexia—Mycophenolic acid—systemic scleroderma	0.000795	0.00224	CcSEcCtD
Trimethadione—Insomnia—Leflunomide—systemic scleroderma	0.000791	0.00223	CcSEcCtD
Trimethadione—Paraesthesia—Leflunomide—systemic scleroderma	0.000785	0.00221	CcSEcCtD
Trimethadione—Discomfort—Lisinopril—systemic scleroderma	0.000774	0.00218	CcSEcCtD
Trimethadione—Vomiting—Mometasone—systemic scleroderma	0.000768	0.00216	CcSEcCtD
Trimethadione—Feeling abnormal—Azathioprine—systemic scleroderma	0.000763	0.00215	CcSEcCtD
Trimethadione—Rash—Mometasone—systemic scleroderma	0.000762	0.00214	CcSEcCtD
Trimethadione—Asthenia—Captopril—systemic scleroderma	0.000761	0.00214	CcSEcCtD
Trimethadione—Dermatitis—Mometasone—systemic scleroderma	0.000761	0.00214	CcSEcCtD
Trimethadione—Decreased appetite—Leflunomide—systemic scleroderma	0.00076	0.00214	CcSEcCtD
Trimethadione—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000757	0.00213	CcSEcCtD
Trimethadione—Headache—Mometasone—systemic scleroderma	0.000757	0.00213	CcSEcCtD
Trimethadione—Insomnia—Mycophenolic acid—systemic scleroderma	0.000754	0.00212	CcSEcCtD
Trimethadione—Fatigue—Leflunomide—systemic scleroderma	0.000754	0.00212	CcSEcCtD
Trimethadione—Pruritus—Captopril—systemic scleroderma	0.000751	0.00211	CcSEcCtD
Trimethadione—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000749	0.00211	CcSEcCtD
Trimethadione—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000748	0.00211	CcSEcCtD
Trimethadione—Somnolence—Mycophenolic acid—systemic scleroderma	0.000741	0.00209	CcSEcCtD
Trimethadione—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000736	0.00207	CcSEcCtD
Trimethadione—Neutropenia—Prednisone—systemic scleroderma	0.000734	0.00207	CcSEcCtD
Trimethadione—Abdominal pain—Azathioprine—systemic scleroderma	0.000732	0.00206	CcSEcCtD
Trimethadione—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000727	0.00205	CcSEcCtD
Trimethadione—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000725	0.00204	CcSEcCtD
Trimethadione—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000725	0.00204	CcSEcCtD
Trimethadione—Irritability—Methotrexate—systemic scleroderma	0.000724	0.00204	CcSEcCtD
Trimethadione—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000722	0.00203	CcSEcCtD
Trimethadione—Feeling abnormal—Leflunomide—systemic scleroderma	0.00072	0.00203	CcSEcCtD
Trimethadione—Fatigue—Mycophenolic acid—systemic scleroderma	0.000719	0.00203	CcSEcCtD
Trimethadione—Nausea—Mometasone—systemic scleroderma	0.000717	0.00202	CcSEcCtD
Trimethadione—Anorexia—Lisinopril—systemic scleroderma	0.000716	0.00202	CcSEcCtD
Trimethadione—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000715	0.00201	CcSEcCtD
Trimethadione—Weight decreased—Prednisone—systemic scleroderma	0.00071	0.002	CcSEcCtD
Trimethadione—Abdominal pain—Leflunomide—systemic scleroderma	0.000691	0.00195	CcSEcCtD
Trimethadione—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000687	0.00194	CcSEcCtD
Trimethadione—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000682	0.00192	CcSEcCtD
Trimethadione—Insomnia—Lisinopril—systemic scleroderma	0.000679	0.00191	CcSEcCtD
Trimethadione—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000678	0.00191	CcSEcCtD
Trimethadione—Paraesthesia—Lisinopril—systemic scleroderma	0.000675	0.0019	CcSEcCtD
Trimethadione—Vomiting—Captopril—systemic scleroderma	0.000674	0.0019	CcSEcCtD
Trimethadione—Rash—Captopril—systemic scleroderma	0.000669	0.00188	CcSEcCtD
Trimethadione—Dermatitis—Captopril—systemic scleroderma	0.000668	0.00188	CcSEcCtD
Trimethadione—Somnolence—Lisinopril—systemic scleroderma	0.000668	0.00188	CcSEcCtD
Trimethadione—Headache—Captopril—systemic scleroderma	0.000665	0.00187	CcSEcCtD
Trimethadione—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000659	0.00186	CcSEcCtD
Trimethadione—Decreased appetite—Lisinopril—systemic scleroderma	0.000653	0.00184	CcSEcCtD
Trimethadione—Eosinophilia—Methotrexate—systemic scleroderma	0.000649	0.00183	CcSEcCtD
Trimethadione—Fatigue—Lisinopril—systemic scleroderma	0.000648	0.00182	CcSEcCtD
Trimethadione—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000644	0.00181	CcSEcCtD
Trimethadione—Haemoglobin—Prednisone—systemic scleroderma	0.000631	0.00178	CcSEcCtD
Trimethadione—Nausea—Captopril—systemic scleroderma	0.00063	0.00177	CcSEcCtD
Trimethadione—Haemorrhage—Prednisone—systemic scleroderma	0.000628	0.00177	CcSEcCtD
Trimethadione—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000627	0.00177	CcSEcCtD
Trimethadione—Asthenia—Leflunomide—systemic scleroderma	0.000627	0.00177	CcSEcCtD
Trimethadione—Pancytopenia—Methotrexate—systemic scleroderma	0.000623	0.00175	CcSEcCtD
Trimethadione—Feeling abnormal—Lisinopril—systemic scleroderma	0.000619	0.00174	CcSEcCtD
Trimethadione—Pruritus—Leflunomide—systemic scleroderma	0.000619	0.00174	CcSEcCtD
Trimethadione—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000614	0.00173	CcSEcCtD
Trimethadione—Neutropenia—Methotrexate—systemic scleroderma	0.000613	0.00173	CcSEcCtD
Trimethadione—Asthenia—Mycophenolic acid—systemic scleroderma	0.000598	0.00169	CcSEcCtD
Trimethadione—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000595	0.00168	CcSEcCtD
Trimethadione—Abdominal pain—Lisinopril—systemic scleroderma	0.000594	0.00167	CcSEcCtD
Trimethadione—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000591	0.00166	CcSEcCtD
Trimethadione—Pruritus—Mycophenolic acid—systemic scleroderma	0.00059	0.00166	CcSEcCtD
Trimethadione—Vomiting—Azathioprine—systemic scleroderma	0.000589	0.00166	CcSEcCtD
Trimethadione—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00165	CcSEcCtD
Trimethadione—Drowsiness—Methotrexate—systemic scleroderma	0.000585	0.00165	CcSEcCtD
Trimethadione—Rash—Azathioprine—systemic scleroderma	0.000584	0.00164	CcSEcCtD
Trimethadione—Dermatitis—Azathioprine—systemic scleroderma	0.000583	0.00164	CcSEcCtD
Trimethadione—Headache—Azathioprine—systemic scleroderma	0.00058	0.00163	CcSEcCtD
Trimethadione—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000572	0.00161	CcSEcCtD
Trimethadione—Vomiting—Leflunomide—systemic scleroderma	0.000556	0.00157	CcSEcCtD
Trimethadione—Alopecia—Prednisone—systemic scleroderma	0.000555	0.00156	CcSEcCtD
Trimethadione—Epistaxis—Methotrexate—systemic scleroderma	0.000551	0.00155	CcSEcCtD
Trimethadione—Rash—Leflunomide—systemic scleroderma	0.000551	0.00155	CcSEcCtD
Trimethadione—Dermatitis—Leflunomide—systemic scleroderma	0.000551	0.00155	CcSEcCtD
Trimethadione—Nausea—Azathioprine—systemic scleroderma	0.00055	0.00155	CcSEcCtD
Trimethadione—Headache—Leflunomide—systemic scleroderma	0.000548	0.00154	CcSEcCtD
Trimethadione—Agranulocytosis—Methotrexate—systemic scleroderma	0.000546	0.00154	CcSEcCtD
Trimethadione—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000542	0.00153	CcSEcCtD
Trimethadione—Asthenia—Lisinopril—systemic scleroderma	0.000539	0.00152	CcSEcCtD
Trimethadione—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000538	0.00152	CcSEcCtD
Trimethadione—Pruritus—Lisinopril—systemic scleroderma	0.000532	0.0015	CcSEcCtD
Trimethadione—Vomiting—Mycophenolic acid—systemic scleroderma	0.00053	0.00149	CcSEcCtD
Trimethadione—Haemoglobin—Methotrexate—systemic scleroderma	0.000528	0.00149	CcSEcCtD
Trimethadione—Rash—Mycophenolic acid—systemic scleroderma	0.000526	0.00148	CcSEcCtD
Trimethadione—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000525	0.00148	CcSEcCtD
Trimethadione—Hepatitis—Methotrexate—systemic scleroderma	0.000525	0.00148	CcSEcCtD
Trimethadione—Haemorrhage—Methotrexate—systemic scleroderma	0.000525	0.00148	CcSEcCtD
Trimethadione—Headache—Mycophenolic acid—systemic scleroderma	0.000523	0.00147	CcSEcCtD
Trimethadione—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00052	0.00147	CcSEcCtD
Trimethadione—Nausea—Leflunomide—systemic scleroderma	0.000519	0.00146	CcSEcCtD
Trimethadione—Ill-defined disorder—Prednisone—systemic scleroderma	0.000507	0.00143	CcSEcCtD
Trimethadione—Erythema multiforme—Methotrexate—systemic scleroderma	0.000496	0.0014	CcSEcCtD
Trimethadione—Nausea—Mycophenolic acid—systemic scleroderma	0.000495	0.0014	CcSEcCtD
Trimethadione—Malaise—Prednisone—systemic scleroderma	0.000493	0.00139	CcSEcCtD
Trimethadione—Vertigo—Prednisone—systemic scleroderma	0.000491	0.00138	CcSEcCtD
Trimethadione—Vomiting—Lisinopril—systemic scleroderma	0.000478	0.00135	CcSEcCtD
Trimethadione—Rash—Lisinopril—systemic scleroderma	0.000474	0.00133	CcSEcCtD
Trimethadione—Dermatitis—Lisinopril—systemic scleroderma	0.000473	0.00133	CcSEcCtD
Trimethadione—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000472	0.00133	CcSEcCtD
Trimethadione—Headache—Lisinopril—systemic scleroderma	0.000471	0.00133	CcSEcCtD
Trimethadione—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000466	0.00131	CcSEcCtD
Trimethadione—Alopecia—Methotrexate—systemic scleroderma	0.000464	0.00131	CcSEcCtD
Trimethadione—Discomfort—Prednisone—systemic scleroderma	0.00046	0.0013	CcSEcCtD
Trimethadione—Nausea—Lisinopril—systemic scleroderma	0.000446	0.00126	CcSEcCtD
Trimethadione—Anorexia—Prednisone—systemic scleroderma	0.000425	0.0012	CcSEcCtD
Trimethadione—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000424	0.00119	CcSEcCtD
Trimethadione—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000419	0.00118	CcSEcCtD
Trimethadione—Rash—Mycophenolate mofetil—systemic scleroderma	0.000415	0.00117	CcSEcCtD
Trimethadione—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000415	0.00117	CcSEcCtD
Trimethadione—Headache—Mycophenolate mofetil—systemic scleroderma	0.000412	0.00116	CcSEcCtD
Trimethadione—Malaise—Methotrexate—systemic scleroderma	0.000412	0.00116	CcSEcCtD
Trimethadione—Vertigo—Methotrexate—systemic scleroderma	0.00041	0.00116	CcSEcCtD
Trimethadione—Leukopenia—Methotrexate—systemic scleroderma	0.000409	0.00115	CcSEcCtD
Trimethadione—Insomnia—Prednisone—systemic scleroderma	0.000404	0.00114	CcSEcCtD
Trimethadione—Paraesthesia—Prednisone—systemic scleroderma	0.000401	0.00113	CcSEcCtD
Trimethadione—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000391	0.0011	CcSEcCtD
Trimethadione—Decreased appetite—Prednisone—systemic scleroderma	0.000388	0.00109	CcSEcCtD
Trimethadione—Fatigue—Prednisone—systemic scleroderma	0.000385	0.00108	CcSEcCtD
Trimethadione—Discomfort—Methotrexate—systemic scleroderma	0.000384	0.00108	CcSEcCtD
Trimethadione—Feeling abnormal—Prednisone—systemic scleroderma	0.000368	0.00104	CcSEcCtD
Trimethadione—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000365	0.00103	CcSEcCtD
Trimethadione—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000365	0.00103	CcSEcCtD
Trimethadione—Anorexia—Methotrexate—systemic scleroderma	0.000355	0.001	CcSEcCtD
Trimethadione—Abdominal pain—Prednisone—systemic scleroderma	0.000353	0.000993	CcSEcCtD
Trimethadione—Insomnia—Methotrexate—systemic scleroderma	0.000337	0.00095	CcSEcCtD
Trimethadione—Paraesthesia—Methotrexate—systemic scleroderma	0.000335	0.000943	CcSEcCtD
Trimethadione—Somnolence—Methotrexate—systemic scleroderma	0.000331	0.000934	CcSEcCtD
Trimethadione—Decreased appetite—Methotrexate—systemic scleroderma	0.000324	0.000913	CcSEcCtD
Trimethadione—Fatigue—Methotrexate—systemic scleroderma	0.000321	0.000905	CcSEcCtD
Trimethadione—Asthenia—Prednisone—systemic scleroderma	0.00032	0.000902	CcSEcCtD
Trimethadione—Pruritus—Prednisone—systemic scleroderma	0.000316	0.000889	CcSEcCtD
Trimethadione—Feeling abnormal—Methotrexate—systemic scleroderma	0.000307	0.000865	CcSEcCtD
Trimethadione—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000305	0.000859	CcSEcCtD
Trimethadione—Abdominal pain—Methotrexate—systemic scleroderma	0.000295	0.00083	CcSEcCtD
Trimethadione—Vomiting—Prednisone—systemic scleroderma	0.000284	0.000799	CcSEcCtD
Trimethadione—Rash—Prednisone—systemic scleroderma	0.000281	0.000792	CcSEcCtD
Trimethadione—Dermatitis—Prednisone—systemic scleroderma	0.000281	0.000792	CcSEcCtD
Trimethadione—Headache—Prednisone—systemic scleroderma	0.00028	0.000787	CcSEcCtD
Trimethadione—Asthenia—Methotrexate—systemic scleroderma	0.000268	0.000753	CcSEcCtD
Trimethadione—Nausea—Prednisone—systemic scleroderma	0.000265	0.000746	CcSEcCtD
Trimethadione—Pruritus—Methotrexate—systemic scleroderma	0.000264	0.000743	CcSEcCtD
Trimethadione—CYP2C19—digestive system—systemic scleroderma	0.000257	0.0392	CbGeAlD
Trimethadione—Vomiting—Methotrexate—systemic scleroderma	0.000237	0.000668	CcSEcCtD
Trimethadione—Rash—Methotrexate—systemic scleroderma	0.000235	0.000662	CcSEcCtD
Trimethadione—Dermatitis—Methotrexate—systemic scleroderma	0.000235	0.000662	CcSEcCtD
Trimethadione—Headache—Methotrexate—systemic scleroderma	0.000234	0.000658	CcSEcCtD
Trimethadione—Nausea—Methotrexate—systemic scleroderma	0.000221	0.000624	CcSEcCtD
Trimethadione—CYP2C9—digestive system—systemic scleroderma	0.000199	0.0304	CbGeAlD
Trimethadione—CYP2E1—digestive system—systemic scleroderma	0.000189	0.0288	CbGeAlD
Trimethadione—CYP2E1—tendon—systemic scleroderma	0.00018	0.0274	CbGeAlD
Trimethadione—CYP2E1—lung—systemic scleroderma	0.000158	0.024	CbGeAlD
Trimethadione—CYP3A4—digestive system—systemic scleroderma	0.000152	0.0232	CbGeAlD
